Kingsview Wealth Management, LLC
Position in BMY — Bristol Myers Squibb Co
CIK 1791965
GRANTS PASS, OR
Position in BMY
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$2,598,258
-$4,380,616 QoQ
Shares Held
45,093
-60.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#735
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Derivatives in BMY
reported options exposure · as of Sep 30, 2021CallValue
$17,751
CallShares
300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kingsview Wealth Management, LLC holds $172,226,536 across 14 Drug Manufacturers - General names. BMY ranks #7 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
82,083 | $98,452,820 | |
| 2 | JNJ |
Johnson & Johnson
|
94,143 | $23,909,497 | |
| 3 | ABBV |
AbbVie Inc.
|
71,689 | $18,039,819 | |
| 4 | MRK |
Merck & Co., Inc.
|
80,440 | $10,336,540 | |
| 5 | AMGN |
Amgen Inc
|
18,729 | $6,782,145 | |
| 6 | PFE |
Pfizer Inc
|
212,065 | $5,106,525 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
45,093 | $2,598,258 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
17,845 | $2,254,537 |
All Filings in BMY
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,598,258 | 45,093 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $6,978,874 | 115,068 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,470,991 | 45,810 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,373,475 | 30,454 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,431,009 | 30,914 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $5,554,968 | 91,080 | Shares | Defined | 2025-05-02 | |
| 2024-12-31 | $1,793,970 | 31,718 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $4,899,467 | 94,694 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,360,149 | 32,751 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,527,071 | 175,679 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $8,536,034 | 166,362 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,793,030 | 65,352 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $3,615,860 | 56,542 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,825,288 | 55,191 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,625,665 | 64,290 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,375,234 | 61,545 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $5,191,648 | 67,424 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $3,786,751 | 51,852 | Shares | Sole | 2024-02-08 | |
| 2021-12-31 | $3,198,929 | 51,306 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $17,751 | 300 | Call | Sole | 2021-12-03 | |
| 2021-09-30 | $2,907,377 | 49,136 | Shares | Sole | 2021-12-03 | |
| 2021-06-30 | $3,009,840 | 45,044 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $2,928,663 | 46,391 | Shares | Sole | 2021-05-24 | |
| 2020-12-31 | $4,011,914 | 64,677 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,808,097 | 63,163 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $3,660,417 | 62,252 | Shares | Sole | 2020-08-14 | |
| 2020-06-30 | $1,000 | 300 | Call | Sole | 2020-08-14 | |
| 2020-03-31 | $2,233,278 | 40,066 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||